NCT01606553

Brief Summary

The purpose of this study is to determine whether a high intensity short duration inspiratory muscle training is feasible, secure and effective to improve respiratory muscle function (strength and resistance), health-related quality of life, and to assess potential correlations with health resources utilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 25, 2012

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

February 17, 2016

Status Verified

February 1, 2016

Enrollment Period

1.3 years

First QC Date

May 21, 2012

Last Update Submit

February 15, 2016

Conditions

Keywords

chronic heart failurerespiratory muscle weaknessinspiratory muscle training

Outcome Measures

Primary Outcomes (1)

  • Change in respiratory muscle function strength

    Transducer measuring maximal inspiratory and expiratory pressures

    Baseline to 4 weeks

Secondary Outcomes (3)

  • Change in health-related quality of life

    Baseline to 4 weeks

  • Adverse effects from training

    Baseline to week 4

  • Health care utilization

    Baseline to one year

Study Arms (2)

High-intensity IMT

EXPERIMENTAL

High intensity short duration respiratory muscle training (IMT) using a dual-vave prototype

Device: High-intensity IMT

Sham High-intensity IMT

ACTIVE COMPARATOR

High intensity short duration respiratory muscle training (IMT) using a sham dual-vave prototype

Device: Sham High-intensity IMT

Interventions

High intensity short duration respiratory muscle training with a valve prototype

Also known as: Orygen-Dual valve prototype
High-intensity IMT

High intensity short duration respiratory muscle training using a sham valve prototype

Also known as: Sham Orygen-Dual valve prototype
Sham High-intensity IMT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 years;
  • chronic heart failure (CHF) of any etiology;
  • clinically stable condition, with no worsening of heart failure or change in cardiac medication in the previous 3 months and during the study; and
  • ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.

You may not qualify if:

  • previous history of any chronic respiratory disease;
  • not to have performed any kind of general or respiratory training in the previous 3 months.
  • Prior to randomization, all patients' clinical assessment and echocardiographic measurements were done by a cardiologist and all patients underwent pulmonary function tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital del Mar

Barcelona, Barcelona, 08003, Spain

Location

Related Publications (1)

  • Marco E, Ramirez-Sarmiento AL, Coloma A, Sartor M, Comin-Colet J, Vila J, Enjuanes C, Bruguera J, Escalada F, Gea J, Orozco-Levi M. High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trial. Eur J Heart Fail. 2013 Aug;15(8):892-901. doi: 10.1093/eurjhf/hft035. Epub 2013 Mar 19.

Study Officials

  • Ferran Escalada, MD, PhD

    Parc de Salut Mar

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 21, 2012

First Posted

May 25, 2012

Study Start

October 1, 2010

Primary Completion

January 1, 2012

Study Completion

June 1, 2012

Last Updated

February 17, 2016

Record last verified: 2016-02

Locations